Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Sasca, Daniel; Guezguez, Borhane; Kuhn, Michael W. M.
Next generation epigenetic modulators to target myeloid neoplasmsCURRENT OPINION IN HEMATOLOGY. Bd. 28. H. 5. 2021 S. 356-363
Rasche, Leo; Wasch, Ralph; Munder, Markus et al.
Novel immunotherapies in multiple myeloma - chances and challengesHAEMATOLOGICA. Bd. 106. H. 10. 2021 S. 2555-2565
Mogensen, Hanna; Modig, Karin; Talback, Mats et al.
Number of siblings and survival from childhood leukaemia: a national register-based cohort study from SwedenBRITISH JOURNAL OF CANCER. Bd. 125. H. 1. 2021 S. 112-118
Seifen, Christopher; Huppertz, Tilman; Matthias, Christoph et al.
Obstructive Sleep Apnea in Patients with Head and Neck Cancer-More than Just a Comorbidity?MEDICINA-LITHUANIA. Bd. 57. H. 11. 2021
Pons, Miriam; Zeyn, Yanira; Zahn, Stella et al.
Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis InhibitionCANCERS. Bd. 13. H. 14. 2021
Pfisterer, Jacobus; Joly, Florence; Kristensen, Gunnar et al.
Optimal treatment duration of bevacizumab (BEV) combined with carboplatin and paclitaxel in patients (pts) with primary epithelial ovarian (EOC), fallopian tube (FTC) or peritoneal cancer (PPC): A multicenter open-label randomized 2-arm phase 3 ENGOT/GCIG trial of the AGO Study Group, GINECO, and NSGO (AGO-OVAR 17/BOOST, GINECO OV118, ENGOT Ov-15, NCT01462890).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Gerlach, Christina; Mai, Sandra Stephanie; Schmidtmann, Irene et al.
Palliative care in undergraduate medical education consolidation of the learning contents of palliative care in the final academic yearGMS JOURNAL FOR MEDICAL EDUCATION. Bd. 38. H. 6. 2021
Borgmann, Hendrik; Hofner, Thomas; Sasca, Daniel et al.
Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic OncologyEUROPEAN UROLOGY. Bd. 79. H. 6. 2021 S. 895-896
Schmidt, M
Pathologie, Prognose und PrädiktionUntch / Harbeck / Thomssen (Hrsg). Colloquium Senologie 2021 / 2022. München: Agileum 2021
Galle, Peter R.; Finn, Richard S.; Qin, Shukui et al.
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trialLANCET ONCOLOGY. Bd. 22. H. 7. 2021 S. 991-1001